Viridian Therapeutics, Inc. VRDN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2B.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s market capitalization?
- Viridian Therapeutics, Inc. (VRDN) reported market capitalization of $2B in Q1 2026.
- How has Viridian Therapeutics, Inc.'s market capitalization changed year-over-year?
- Viridian Therapeutics, Inc.'s market capitalization increased by 82.0% year-over-year, from $1.1B to $2B.
- What is the long-term trend for Viridian Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s market capitalization has grown at a 95.4% compound annual growth rate (CAGR), from $104.23M to $2.97B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.